Literature DB >> 28390707

Human infections with recently-emerging highly pathogenic H7N9 avian influenza virus in China.

Fuchun Zhang1, Yuhai Bi2, Jian Wang3, Gary Wong2, Weifeng Shi4, Fengyu Hu3, Yang Yang5, Liuqing Yang5, Xilong Deng3, Songfeng Jiang3, Xi He3, Yingxia Liu5, Chibiao Yin3, Nanshan Zhong6, George F Gao7.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28390707     DOI： 10.1016/j.jinf.2017.04.001

Source DB:  PubMed          Journal:  J Infect        ISSN： 0163-4453            Impact factor:   6.072


× No keyword cloud information.
  60 in total

1.  Highly pathogenic avian influenza H7N9 viruses with reduced susceptibility to neuraminidase inhibitors showed comparable replication capacity to their sensitive counterparts.

Authors:  Jing Tang; Jing Zhang; Jianfang Zhou; Wenfei Zhu; Lei Yang; Shumei Zou; Hejiang Wei; Li Xin; Weijuan Huang; Xiyan Li; Yanhui Cheng; Dayan Wang
Journal:  Virol J       Date:  2019-07-02       Impact factor: 4.099

2.  Multiple amino acid substitutions involved in the adaption of three avian-origin H7N9 influenza viruses in mice.

Authors:  Jianru Qin; Ouyang Peng; Xiaoting Shen; Lang Gong; Chunyi Xue; Yongchang Cao
Journal:  Virol J       Date:  2019-01-08       Impact factor: 4.099

3.  Genesis and Spread of Newly Emerged Highly Pathogenic H7N9 Avian Viruses in Mainland China.

Authors:  Lei Yang; Wenfei Zhu; Xiyan Li; Minmei Chen; Jie Wu; Pengbo Yu; Shunxiang Qi; Yiwei Huang; Weixian Shi; Jie Dong; Xiang Zhao; Weijuan Huang; Zi Li; Xiaoxu Zeng; Hong Bo; Tao Chen; Wenbing Chen; Jia Liu; Ye Zhang; Zhenli Liang; Wei Shi; Yuelong Shu; Dayan Wang
Journal:  J Virol       Date:  2017-11-14       Impact factor: 5.103

4.  Identification of key hemagglutinin residues responsible for cleavage, acid stability, and virulence of fifth-wave highly pathogenic avian influenza A(H7N9) viruses.

Authors:  Xiangjie Sun; Jessica A Belser; Hua Yang; Joanna A Pulit-Penaloza; Claudia Pappas; Nicole Brock; Hui Zeng; Hannah M Creager; James Stevens; Taronna R Maines
Journal:  Virology       Date:  2019-07-12       Impact factor: 3.616

5.  Structural and Molecular Characterization of the Hemagglutinin from the Fifth-Epidemic-Wave A(H7N9) Influenza Viruses.

Authors:  Hua Yang; Paul J Carney; Jessie C Chang; Zhu Guo; James Stevens
Journal:  J Virol       Date:  2018-07-31       Impact factor: 5.103

6.  Avian Influenza A (H7N9) Virus in a Wild Land Bird in Central China, Late 2015.

Authors:  Yanfeng Yao; Tao Zhang; Wenhai Yang; Zhiyong Shao; Bin He; Xiabing Chen; Lijun Wu; Erguang Jin; Haizhou Liu; Jianjun Chen; Jie Chen
Journal:  Virol Sin       Date:  2018-03-05       Impact factor: 4.327

7.  H7N9 avian influenza A virus in China: a short report on its circulation, drug resistant mutants and novel antiviral drugs.

Authors:  Bao Danqi; Zejun Li; Qinfang Liu; Juergen A Richt
Journal:  Expert Rev Anti Infect Ther       Date:  2017-07-17       Impact factor: 5.091

Review 8.  Novel Influenza D virus: Epidemiology, pathology, evolution and biological characteristics.

Authors:  Shuo Su; Xinliang Fu; Gairu Li; Fiona Kerlin; Michael Veit
Journal:  Virulence       Date:  2017-08-25       Impact factor: 5.882

9.  Pathogenesis of Influenza A(H7N9) Virus in Aged Nonhuman Primates.

Authors:  Satoshi Fukuyama; Kiyoko Iwatsuki-Horimoto; Maki Kiso; Noriko Nakajima; Robert W Gregg; Hiroaki Katsura; Yuriko Tomita; Tadashi Maemura; Tiago Jose da Silva Lopes; Tokiko Watanabe; Jason E Shoemaker; Hideki Hasegawa; Seiya Yamayoshi; Yoshihiro Kawaoka
Journal:  J Infect Dis       Date:  2020-09-01       Impact factor: 5.226

10.  New Threats from H7N9 Influenza Virus: Spread and Evolution of High- and Low-Pathogenicity Variants with High Genomic Diversity in Wave Five.

Authors:  Chuansong Quan; Weifeng Shi; Yang Yang; Yongchun Yang; Xiaoqing Liu; Wen Xu; Hong Li; Juan Li; Qianli Wang; Zhou Tong; Gary Wong; Cheng Zhang; Sufang Ma; Zhenghai Ma; Guanghua Fu; Zewu Zhang; Yu Huang; Houhui Song; Liuqing Yang; William J Liu; Yingxia Liu; Wenjun Liu; George F Gao; Yuhai Bi
Journal:  J Virol       Date:  2018-05-14       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.